India's first Endoscopic Ultrasonography (EUS) service was launched in this centre in the year 1998 and then followed by the launch of interventional EUS in 2001.
The procedure of Narrow Band Imaging (NBI) was launched subsequently in the year 2006. Being equipped with India's most sophisticated EUS and endoscopic equipment from the Olympus Optical Company (Mumbai's first Olympus / Aloka Electronic EUS machine) this division has evolved to be the tertiary referral centre for Diagnostic and Interventional EUS procedures in India.
The main indications for performing a Narrow Band Imaging (NBI) examination are to pick up dysplastic changes in the esophageal, gastric or colonic mucosa and then take targeted biopsies from it. With this technique, cancers of the upper GI tract can be picked up in the early stage when they are amenable for cure.
Diagnostic EUS is commonly performed to stage esophageal cancer, detect Bile duct stones, detect microlithiasis in the gall bladder, pick up pancreas divisum, detect masses in the Mediastinum, detect nature of submucosal tumors, stage pancreatic or biliary cancers and also sometimes colonic cancers.
Interventional EUS is done mainly for acquiring Fine needle aspiration (FNAC) from peri-luminal masses like pancreatic cancers, mediastinal masses, bile duct cancers, gall bladder cancers, peri-gastric or peri-colonic masses.
Therapeutic EUS is performed for assisting biliary or pancreatic cannulation in case of a failed ERCP or performing a direct EUS guided drainage of the biliary and pancreatic system.
These diagnostic, interventional and therapeutic EUS procedures are routinely performed in this centre by our team of highly experienced and qualified doctors.
The Abheraj Baldota Cancer Detection Centre is also credited of imparting training in EUS to aspiring Gastroenterologists and Surgeons over the past 10 years.
Trainees from India and abroad routinely come here for learning the basic and advanced skills of EUS.
A very recent addition to its credit is the ongoing research on EUS guided genomic analysis of cancer cells to detect cancer behaviour